[ Search ] [ Legislation ]
[ Home ] [ Back ] [ Bottom ]
| [ Introduced ] | [ Engrossed ] | [ Enrolled ] |
| [ House Amendment 001 ] | [ House Amendment 002 ] | [ Senate Amendment 001 ] |
| [ Senate Amendment 003 ] |
91_HB2574sam004
LRB9104866DJcdam04
1 AMENDMENT TO HOUSE BILL 2574
2 AMENDMENT NO. . Amend House Bill 2574, AS AMENDED,
3 by replacing the title with the following:
4 "AN ACT to amend the Illinois Controlled Substances
5 Act."; and
6 by replacing the introductory clause of Section 5 with the
7 following:
8 "Section 5. The Illinois Controlled Substances Act is
9 amended by changing Sections 102, 201, 204, 206, 208, 210,
10 214, 309, 312, 313, and 316 and adding Section 217 as
11 follows:"; and
12 in Section 5, after the last line of Sec. 201, by inserting
13 the following:
14 "(720 ILCS 570/204) (from Ch. 56 1/2, par. 1204)
15 Sec. 204. (a) The controlled substances listed in this
16 Section are included in Schedule I.
17 (b) Unless specifically excepted or unless listed in
18 another schedule, any of the following opiates, including
19 their isomers, esters, ethers, salts, and salts of isomers,
20 esters, and ethers, whenever the existence of such isomers,
21 esters, ethers and salts is possible within the specific
-2- LRB9104866DJcdam04
1 chemical designation:
2 (1) Acetylmethadol;
3 (1.1) Acetyl-alpha-methylfentanyl
4 (N-[1-(1-methyl-2-phenethyl)-
5 4-piperidinyl]-N-phenylacetamide);
6 (2) Allylprodine;
7 (3) Alphacetylmethadol, except
8 levo-alphacetylmethadol (also known as levo-alpha-
9 acetylmethadol, levomethadyl acetate, or LAAM);
10 (4) Alphameprodine;
11 (5) Alphamethadol;
12 (6) Alpha-methylfentanyl
13 (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
14 propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-
15 propanilido) piperidine;
16 (6.1) Alpha-methylthiofentanyl
17 (N-[1-methyl-2-(2-thienyl)ethyl-
18 4-piperidinyl]-N-phenylpropanamide);
19 (7) 1-methyl-4-phenyl-4-proprionoxypiperidine
20 (MPPP);
21 (7.1) PEPAP
22 (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
23 (8) Benzethidine;
24 (9) Betacetylmethadol;
25 (9.1) Beta-hydroxyfentanyl
26 (N-[1-(2-hydroxy-2-phenethyl)-
27 4-piperidinyl]-N-phenylpropanamide);
28 (10) Betameprodine;
29 (11) Betamethadol;
30 (12) Betaprodine;
31 (13) Clonitazene;
32 (14) Dextromoramide;
33 (15) Diampromide;
34 (16) Diethylthiambutene;
-3- LRB9104866DJcdam04
1 (17) Difenoxin;
2 (18) Dimenoxadol;
3 (19) Dimepheptanol;
4 (20) Dimethylthiambutene;
5 (21) Dioxaphetylbutyrate;
6 (22) Dipipanone;
7 (23) Ethylmethylthiambutene;
8 (24) Etonitazene;
9 (25) Etoxeridine;
10 (26) Furethidine;
11 (27) Hydroxpethidine;
12 (28) Ketobemidone;
13 (29) Levomoramide;
14 (30) Levophenacylmorphan;
15 (31) 3-Methylfentanyl
16 (N-[3-methyl-1-(2-phenylethyl)-
17 4-piperidyl]-N-phenylpropanamide);
18 (31.1) 3-Methylthiofentanyl
19 (N-[(3-methyl-1-(2-thienyl)ethyl-
20 4-piperidinyl]-N-phenylpropanamide);
21 (32) Morpheridine;
22 (33) Noracymethadol;
23 (34) Norlevorphanol;
24 (35) Normethadone;
25 (36) Norpipanone;
26 (36.1) Para-fluorofentanyl
27 (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
28 4-piperidinyl]propanamide);
29 (37) Phenadoxone;
30 (38) Phenampromide;
31 (39) Phenomorphan;
32 (40) Phenoperidine;
33 (41) Piritramide;
34 (42) Proheptazine;
-4- LRB9104866DJcdam04
1 (43) Properidine;
2 (44) Propiram;
3 (45) Racemoramide;
4 (45.1) Thiofentanyl
5 (N-phenyl-N-[1-(2-thienyl)ethyl-
6 4-piperidinyl]-propanamide);
7 (46) Tilidine;
8 (47) Trimeperidine;
9 (48) Beta-hydroxy-3-methylfentanyl (other name:
10 N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
11 N-phenylpropanamide).
12 (c) Unless specifically excepted or unless listed in
13 another schedule, any of the following opium derivatives,
14 its salts, isomers and salts of isomers, whenever the
15 existence of such salts, isomers and salts of isomers is
16 possible within the specific chemical designation:
17 (1) Acetorphine;
18 (2) Acetyldihydrocodeine;
19 (3) Benzylmorphine;
20 (4) Codeine methylbromide;
21 (5) Codeine-N-Oxide;
22 (6) Cyprenorphine;
23 (7) Desomorphine;
24 (8) Diacetyldihydromorphine (Dihydroheroin);
25 (9) Dihydromorphine;
26 (10) Drotebanol;
27 (11) Etorphine (except hydrochloride salt);
28 (12) Heroin;
29 (13) Hydromorphinol;
30 (14) Methyldesorphine;
31 (15) Methyldihydromorphine;
32 (16) Morphine methylbromide;
33 (17) Morphine methylsulfonate;
34 (18) Morphine-N-Oxide;
-5- LRB9104866DJcdam04
1 (19) Myrophine;
2 (20) Nicocodeine;
3 (21) Nicomorphine;
4 (22) Normorphine;
5 (23) Pholcodine;
6 (24) Thebacon.
7 (d) Unless specifically excepted or unless listed in
8 another schedule, any material, compound, mixture, or
9 preparation which contains any quantity of the following
10 hallucinogenic substances, or which contains any of its
11 salts, isomers and salts of isomers, whenever the existence
12 of such salts, isomers, and salts of isomers is possible
13 within the specific chemical designation (for the purposes of
14 this paragraph only, the term "isomer" includes the optical,
15 position and geometric isomers):
16 (1) 3,4-methylenedioxyamphetamine
17 (alpha-methyl,3,4-methylenedioxyphenethylamine,
18 methylenedioxyamphetamine, MDA);
19 (1.1) Alpha-ethyltryptamine
20 (some trade or other names: etryptamine;
21 MONASE; alpha-ethyl-1H-indole-3-ethanamine;
22 3-(2-aminobutyl)indole; a-ET; and AET);
23 (2) 3,4-methylenedioxymethamphetamine (MDMA);
24 (2.1) 3,4-methylenedioxy-N-ethylamphetamine
25 (also known as: N-ethyl-alpha-methyl-
26 3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
27 and MDEA);
28 (3) 3-methoxy-4,5-methylenedioxyamphetamine,
29 (MMDA);
30 (4) 3,4,5-trimethoxyamphetamine (TMA);
31 (5) (Blank);5-hydroxydimethyltryptamine
32 (Bufotenine);
33 (6) Diethyltryptamine (DET);
34 (7) Dimethyltryptamine (DMT);
-6- LRB9104866DJcdam04
1 (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
2 (9) Ibogaine (some trade and other names:
3 7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
4 6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
5 indole; Tabernanthe iboga);
6 (10) Lysergic acid diethylamide;
7 (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
8 (12) Peyote (meaning all parts of the plant
9 presently classified botanically as Lophophora williemaii
10 Lemaire, whether growing or not, the seeds thereof, any
11 extract from any part of that plant, and every compound,
12 manufacture, salts, derivative, mixture, or preparation
13 of that plant, its seeds or extracts);
14 (13) N-ethyl-3-piperidyl benzilate (JB 318);
15 (14) N-methyl-3-piperidyl benzilate;
16 (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
17 (also known as N-hydroxy-alpha-methyl-
18 3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
19 (15) Parahexyl; some trade or other names:
20 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
21 dibenzo (b,d) pyran; Synhexyl;
22 (16) Psilocybin;
23 (17) Psilocyn;
24 (18) Alpha-methyltryptamine (AMT);
25 (19) 2,5-dimethoxyamphetamine
26 (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
27 (20) 4-bromo-2,5-dimethoxyamphetamine
28 (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
29 4-bromo-2,5-DMA);
30 (20.1) 4-Bromo-2,5 dimethoxyphenethylamine. Some
31 trade or other names: 2-(4-bromo-
32 2,5-dimethoxyphenyl)-1-aminoethane; alpha-desmethyl DOB,
33 2CB, Nexus.
34 (21) 4-methoxyamphetamine
-7- LRB9104866DJcdam04
1 (4-methoxy-alpha-methylphenethylamine;
2 paramethoxyamphetamine; PMA);
3 (22) (Blank); Thiophene analog of phencyclidine
4 (TPCP);
5 (23) Ethylamine analog of phencyclidine. Some
6 trade or other names: N-ethyl-l-phenylcyclohexylamine,
7 (l-phenylcyclohexyl) ethylamine, N-(l-phenylcyclohexyl)
8 ethylamine, cyclohexamine, PCE;
9 (24) Pyrrolidine analog of phencyclidine. Some
10 trade or other names: l-(l-phenylcyclohexyl) pyrrolidine,
11 PCPy, PHP;
12 (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
13 (26) 2,5-dimethoxy-4-ethylamphetamine
14 (another name: DOET);
15 (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine
16 (another name: TCPy);
17 (28) (Blank);3,4-methylenedioxy amphetamine;
18 (29) Thiophene analog of phencyclidine (some trade
19 or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
20 2-thienyl analog of phencyclidine; TPCP; TCP);
21 (30) Bufotenine (some trade or other names:
22 3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
23 3-(2-dimethylaminoethyl)-5-indolol;
24 5-hydroxy-N,N-dimethyltryptamine;
25 N,N-dimethylserotonin; mappine).
26 (e) Unless specifically excepted or unless listed in
27 another schedule, any material, compound, mixture, or
28 preparation which contains any quantity of the following
29 substances having a depressant effect on the central nervous
30 system, including its salts, isomers, and salts of isomers
31 whenever the existence of such salts, isomers, and salts of
32 isomers is possible within the specific chemical designation:
33 (1) mecloqualone;
34 (2) methaqualone; and
-8- LRB9104866DJcdam04
1 (3) gamma hydroxybutyric acid.
2 (f) Unless specifically excepted or unless listed in
3 another schedule, any material, compound, mixture, or
4 preparation which contains any quantity of the following
5 substances having a stimulant effect on the central nervous
6 system, including its salts, isomers, and salts of isomers:
7 (1) Fenethylline;
8 (2) N-ethylamphetamine;
9 (3) Aminorex (some other names:
10 2-amino-5-phenyl-2-oxazoline; aminoxaphen;
11 4-5-dihydro-5-phenyl-2-oxazolamine) and its
12 salts, optical isomers, and salts of optical isomers;
13 (4) Methcathinone (some other names:
14 2-methylamino-1-phenylpropan-1-one;
15 Ephedrone; 2-(methylamino)-propiophenone;
16 alpha-(methylamino)propiophenone; N-methylcathinone;
17 methycathinone; Monomethylpropion; UR 1431) and its
18 salts, optical isomers, and salts of optical isomers;
19 (5) Chathinone (some trade or other names:
20 2-aminopropiophenone; alpha-aminopropiophenone;
21 2-amino-1-phenyl-propanone; norephedrone);
22 (6) N,N-dimethylamphetamine (also known as:
23 N,N-alpha-trimethyl-benzeneethanamine;
24 N,N-alpha-trimethylphenethylamine);
25 (7) (+ or -) cis-4-methylaminorex ((+ or -) cis-
26 4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine).
27 (g) Temporary listing of substances subject to emergency
28 scheduling. Any material, compound, mixture, or preparation
29 that contains any quantity of the following substances:
30 (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
31 (benzylfentanyl), its optical isomers, isomers, salts,
32 and salts of isomers;
33 (2) N-[1(2-thienyl)
34 methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
-9- LRB9104866DJcdam04
1 its optical isomers, salts, and salts of isomers.
2 (Source: P.A. 89-202, eff. 10-1-95; 90-382, eff. 8-15-97.)
3 (720 ILCS 570/206) (from Ch. 56 1/2, par. 1206)
4 Sec. 206. (a) The controlled substances listed in this
5 Section are included in Schedule II.
6 (b) Unless specifically excepted or unless listed in
7 another schedule, any of the following substances whether
8 produced directly or indirectly by extraction from substances
9 of vegetable origin, or independently by means of chemical
10 synthesis, or by combination of extraction and chemical
11 synthesis:
12 (1) Opium and opiates, and any salt, compound,
13 derivative or preparation of opium or opiate, excluding
14 apomorphine, dextrorphan, levopropoxyphene, nalbuphine,
15 nalmefene, naloxone, and naltrexone, and their respective
16 salts, but including the following:
17 (i) Raw Opium;
18 (ii) Opium extracts;
19 (iii) Opium fluid extracts;
20 (iv) Powdered opium;
21 (v) Granulated opium;
22 (vi) Tincture of opium;
23 (vii) Codeine;
24 (viii) Ethylmorphine;
25 (ix) Etorphine Hydrochloride;
26 (x) Hydrocodone;
27 (xi) Hydromorphone;
28 (xii) Metopon;
29 (xiii) Morphine;
30 (xiv) Oxycodone;
31 (xv) Oxymorphone;
32 (xvi) Thebaine;
33 (xvii) Thebaine-derived butorphanol.
-10- LRB9104866DJcdam04
1 (2) Any salt, compound, isomer, derivative or
2 preparation thereof which is chemically equivalent or
3 identical with any of the substances referred to in
4 subparagraph (1), but not including the isoquinoline
5 alkaloids of opium;
6 (3) Opium poppy and poppy straw;
7 (4) Coca leaves and any salt, compound, isomer,
8 salt of an isomer, derivative, or preparation of coca
9 leaves including cocaine or ecgonine, and any salt,
10 compound, isomer, derivative, or preparation thereof
11 which is chemically equivalent or identical with any of
12 these substances, but not including decocainized coca
13 leaves or extractions of coca leaves which do not contain
14 cocaine or ecgonine (for the purpose of this paragraph,
15 the term "isomer" includes optical, positional and
16 geometric isomers);
17 (5) Concentrate of poppy straw (the crude extract
18 of poppy straw in either liquid, solid or powder form
19 which contains the phenanthrine alkaloids of the opium
20 poppy).
21 (c) Unless specifically excepted or unless listed in
22 another schedule any of the following opiates, including
23 their isomers, esters, ethers, salts, and salts of isomers,
24 whenever the existence of these isomers, esters, ethers and
25 salts is possible within the specific chemical designation,
26 dextrorphan excepted:
27 (1) Alfentanil;
28 (1.1) Carfentanil;
29 (2) Alphaprodine;
30 (3) Anileridine;
31 (4) Bezitramide;
32 (5) Bulk Dextropropoxyphene (non-dosage forms);
33 (6) Dihydrocodeine;
34 (7) Diphenoxylate;
-11- LRB9104866DJcdam04
1 (8) Fentanyl;
2 (9) Sufentanil;
3 (9.5) Remifentanil;
4 (10) Isomethadone;
5 (11) Levomethorphan;
6 (12) Levorphanol (Levorphan);
7 (13) Metazocine;
8 (14) Methadone;
9 (15) Methadone-Intermediate,
10 4-cyano-2-dimethylamino-4,4-diphenyl-1-butane;
11 (16) Moramide-Intermediate,
12 2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic
13 acid;
14 (17) Pethidine (meperidine);
15 (18) Pethidine-Intermediate-A,
16 4-cyano-1-methyl-4-phenylpiperidine;
17 (19) Pethidine-Intermediate-B,
18 ethyl-4-phenylpiperidine-4-carboxylate;
19 (20) Pethidine-Intermediate-C,
20 1-methyl-4-phenylpiperidine-4-carboxylic acid;
21 (21) Phenazocine;
22 (22) Piminodine;
23 (23) Racemethorphan;
24 (24) Racemorphan;
25 (25) Levo-alphacetylmethadol (some other names:
26 levo-alpha-acetylmethadol, levomethadyl acetate, LAAM).
27 (d) Unless specifically excepted or unless listed in
28 another schedule, any material, compound, mixture, or
29 preparation which contains any quantity of the following
30 substances having a stimulant effect on the central nervous
31 system:
32 (1) Amphetamine, its salts, optical isomers, and
33 salts of its optical isomers;
34 (2) Methamphetamine, its salts, isomers, and salts
-12- LRB9104866DJcdam04
1 of its isomers;
2 (3) Phenmetrazine and its salts;
3 (4) Methylphenidate.
4 (e) Unless specifically excepted or unless listed in
5 another schedule, any material, compound, mixture, or
6 preparation which contains any quantity of the following
7 substances having a depressant effect on the central nervous
8 system, including its salts, isomers, and salts of isomers
9 whenever the existence of such salts, isomers, and salts of
10 isomers is possible within the specific chemical designation:
11 (1) Amobarbital;
12 (2) Secobarbital;
13 (3) Pentobarbital;
14 (4) Pentazocine;
15 (5) Phencyclidine;
16 (6) Gluthethimide;
17 (7) (Blank). Dronabinol (synthetic) in sesame oil
18 and encapsulated in a soft gelatin capsule in a U.S. Food
19 and Drug Administration-approved drug product. Some
20 other names:
21 (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-
22 pentyl-6H-dibenzo[b,d]pyran-1-ol; (-)-delta-9-(trans)-
23 tetrahydrocannabinol.
24 (f) Unless specifically excepted or unless listed in
25 another schedule, any material, compound, mixture, or
26 preparation which contains any quantity of the following
27 substances:
28 (1) Immediate precursor to amphetamine and
29 methamphetamine:
30 (i) Phenylacetone
31 Some trade or other names: phenyl-2-propanone;
32 P2P; benzyl methyl ketone; methyl benzyl ketone.
33 (2) Immediate precursors to phencyclidine:
34 (i) l-phenylcyclohexylamine;
-13- LRB9104866DJcdam04
1 (ii) l-piperidinocyclohexanecarbonitrile
2 (PCC).
3 (3) Nabilone.
4 (Source: P.A. 88-168; 89-202, eff. 10-1-95.)
5 (720 ILCS 570/208) (from Ch. 56 1/2, par. 1208)
6 Sec. 208. (a) The controlled substances listed in this
7 Section are included in Schedule III.
8 (b) Unless specifically excepted or unless listed in
9 another schedule, any material, compound, mixture, or
10 preparation which contains any quantity of the following
11 substances having a stimulant effect on the central nervous
12 system, including its salts, isomers (whether optical
13 position, or geometric), and salts of such isomers whenever
14 the existence of such salts, isomers, and salts of isomers is
15 possible within the specific chemical designation;
16 (1) Those compounds, mixtures, or preparations in
17 dosage unit form containing any stimulant substances
18 listed in Schedule II which compounds, mixtures, or
19 preparations were listed on August 25, 1971, as excepted
20 compounds under Title 21, Code of Federal Regulations,
21 Section 308.32, and any other drug of the quantitative
22 composition shown in that list for those drugs or which
23 is the same except that it contains a lesser quantity of
24 controlled substances;
25 (2) Benzphetamine;
26 (3) Chlorphentermine;
27 (4) Clortermine;
28 (5) Phendimetrazine.
29 (c) Unless specifically excepted or unless listed in
30 another schedule, any material, compound, mixture, or
31 preparation which contains any quantity of the following
32 substances having a potential for abuse associated with a
33 depressant effect on the central nervous system:
-14- LRB9104866DJcdam04
1 (1) Any compound, mixture, or preparation
2 containing amobarbital, secobarbital, pentobarbital or
3 any salt thereof and one or more other active medicinal
4 ingredients which are not listed in any schedule;
5 (2) Any suppository dosage form containing
6 amobarbital, secobarbital, pentobarbital or any salt of
7 any of these drugs and approved by the Federal Food and
8 Drug Administration for marketing only as a suppository;
9 (3) Any substance which contains any quantity of a
10 derivative of barbituric acid, or any salt thereof:
11 (4) Chlorhexadol;
12 (5) Methyprylon;
13 (6) Sulfondiethylmethane;
14 (7) Sulfonethylmethane;
15 (8) Sulfonmethane;
16 (9) Lysergic acid;
17 (10) Lysergic acid amide;
18 (10.1) Tiletamine or zolazepam or both, or any salt
19 of either of them.
20 Some trade or other names for a tiletamine-zolazepam
21 combination product: Telazol.
22 Some trade or other names for Tiletamine:
23 2-(ethylamino)-2-(2-thienyl)-cyclohexanone.
24 Some trade or other names for zolazepam:
25 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-
26 [3,4-e], [1,4]-diazepin-7(1H)-one, and flupyrazapon.
27 (11) Any material, compound, mixture or preparation
28 containing not more than 12.5 milligrams of pentazocine
29 or any of its salts, per 325 milligrams of aspirin;
30 (12) Any material, compound, mixture or preparation
31 containing not more than 12.5 milligrams of pentazocine
32 or any of its salts, per 325 milligrams of acetaminophen;
33 (13) Any material, compound, mixture or preparation
34 containing not more than 50 milligrams of pentazocine or
-15- LRB9104866DJcdam04
1 any of its salts plus naloxone HCl USP 0.5 milligrams,
2 per dosage unit;
3 (14) Ketamine.
4 (d) Nalorphine.
5 (e) Unless specifically excepted or unless listed in
6 another schedule, any material, compound, mixture, or
7 preparation containing limited quantities of any of the
8 following narcotic drugs, or their salts calculated as the
9 free anhydrous base or alkaloid, as set forth below:
10 (1) not more than 1.8 grams of codeine per 100
11 milliliters or not more than 90 milligrams per dosage
12 unit, with an equal or greater quantity of an
13 isoquinoline alkaloid of opium;
14 (2) not more than 1.8 grams of codeine per 100
15 milliliters or not more than 90 milligrams per dosage
16 unit, with one or more active non-narcotic ingredients in
17 recognized therapeutic amounts;
18 (3) not more than 300 milligrams of
19 dihydrocodeinone per 100 milliliters or not more than 15
20 milligrams per dosage unit, with a fourfold or greater
21 quantity of an isoquinoline alkaloid of opium;
22 (4) not more than 300 milligrams of
23 dihydrocodeinone per 100 milliliters or not more than 15
24 milligrams per dosage unit, with one or more active,
25 non-narcotic ingredients in recognized therapeutic
26 amounts;
27 (5) not more than 1.8 grams of dihydrocodeine per
28 100 milliliters or not more than 90 milligrams per dosage
29 unit, with one or more active, non-narcotic ingredients
30 in recognized therapeutic amounts;
31 (6) not more than 300 milligrams of ethylmorphine
32 per 100 milliliters or not more than 15 milligrams per
33 dosage unit, with one or more active, non-narcotic
34 ingredients in recognized therapeutic amounts;
-16- LRB9104866DJcdam04
1 (7) not more than 500 milligrams of opium per 100
2 milliliters or per 100 grams, or not more than 25
3 milligrams per dosage unit, with one or more active,
4 non-narcotic ingredients in recognized therapeutic
5 amounts;
6 (8) not more than 50 milligrams of morphine per 100
7 milliliters or per 100 grams with one or more active,
8 non-narcotic ingredients in recognized therapeutic
9 amounts.
10 (f) Anabolic steroids, except the following anabolic
11 steroids that are exempt:
12 (1) Androgyn L.A.;
13 (2) Andro-Estro 90-4;
14 (3) depANDROGYN;
15 (4) DEPO-T.E.;
16 (5) depTESTROGEN;
17 (6) Duomone;
18 (7) DURATESTRIN;
19 (8) DUO-SPAN II;
20 (9) Estratest;
21 (10) Estratest H.S.;
22 (11) PAN ESTRA TEST;
23 (12) Premarin with Methyltestosterone;
24 (13) TEST-ESTRO Cypionates;
25 (14) Testosterone Cyp 50 Estradiol Cyp 2;
26 (15) Testosterone Cypionate-Estradiol Cypionate
27 injection; and
28 (16) Testosterone Enanthate-Estradiol Valerate
29 injection.
30 (g) Hallucenogenic substances.
31 (1) Dronabinol (synthetic) in sesame oil and
32 encapsulated in a soft gelatin capsule in a U.S. Food and
33 Drug Administration approved product. Some other names
34 for dronabinol: (6aR-trans)-6a,7,8,10a-tetrahydro-
-17- LRB9104866DJcdam04
1 6,6,9-trimetjyl-3-pentyl-6H-debenzo (b,d) pyran-1-ol) or
2 (-)-delta-9-(trans)-tetrahydrocannibinol.
3 (2) (Reserved).
4 (h) The Department may except by rule any compound,
5 mixture, or preparation containing any stimulant or
6 depressant substance listed in subsection (b) from the
7 application of all or any part of this Act if the compound,
8 mixture, or preparation contains one or more active medicinal
9 ingredients not having a stimulant or depressant effect on
10 the central nervous system, and if the admixtures are
11 included therein in combinations, quantity, proportion, or
12 concentration that vitiate the potential for abuse of the
13 substances which have a stimulant or depressant effect on the
14 central nervous system.
15 (Source: P.A. 89-202, eff. 10-1-95; 90-382, eff. 8-15-97.)
16 (720 ILCS 570/210) (from Ch. 56 1/2, par. 1210)
17 Sec. 210. (a) The controlled substances listed in this
18 Section are included in Schedule IV.
19 (b) Unless specifically excepted or unless listed in
20 another schedule, any material, compound, mixture, or
21 preparation containing limited quantities of any of the
22 following narcotic drugs, or their salts calculated as the
23 free anhydrous base or alkaloid, as set forth below:
24 (1) Not more than 1 milligram of difenoxin (DEA
25 Drug Code No. 9618) and not less than 25 micrograms of
26 atropine sulfate per dosage unit.
27 (2) Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1,
28 2-diphenyl-3-methyl-2-propionoxybutane).
29 (c) Unless specifically excepted or unless listed in
30 another schedule, any material, compound, mixture, or
31 preparation which contains any quantity of the following
32 substances having a potential for abuse associated with a
33 depressant effect on the central nervous system:
-18- LRB9104866DJcdam04
1 (1) Alprazolam;
2 (2) Barbital;
3 (2.1) Bromazepam;
4 (2.2) Camazepam;
5 (3) Chloral Betaine;
6 (4) Chloral Hydrate;
7 (5) Chlordiazepoxide;
8 (5.1) Clobazam;
9 (6) Clonazepam;
10 (7) Clorazepate;
11 (7.1) Clotiazepam;
12 (7.2) Cloxazolam;
13 (7.3) Delorazepam;
14 (8) Diazepam;
15 (8.1) Estazolam;
16 (9) Ethchlorvynol;
17 (10) Ethinamate;
18 (10.1) Ethyl loflazepate;
19 (10.2) Fludiazepam;
20 (10.3) Flunitrazepam;
21 (11) Flurazepam;
22 (12) Halazepam;
23 (12.1) Haloxazolam;
24 (12.2) Ketazolam;
25 (12.3) Loprazolam;
26 (13) Lorazepam;
27 (13.1) Lormetazepam;
28 (14) Mebutamate;
29 (14.1) Medazepam;
30 (15) Meprobamate;
31 (16) Methohexital;
32 (17) Methylphenobarbital (Mephobarbital);
33 (17.1) Midazolam;
34 (17.2) Nimetazepam;
-19- LRB9104866DJcdam04
1 (17.3) Nitrazepam;
2 (17.4) Nordiazepam;
3 (18) Oxazepam;
4 (18.1) Oxazolam;
5 (19) Paraldehyde;
6 (20) Petrichloral;
7 (21) Phenobarbital;
8 (21.1) Pinazepam;
9 (22) Prazepam;
10 (22.1) Quazepam;
11 (23) Temazepam;
12 (23.1) Tetrazepam;
13 (24) Triazolam;
14 (24.5) Zaleplon;
15 (25) Zolpidem Zolpidam.
16 (d) Any material, compound, mixture, or preparation
17 which contains any quantity of the following substances,
18 including its salts, isomers (whether optical, position, or
19 geometric), and salts of such isomers, whenever the existence
20 of such salts, isomers and salts of isomers is possible:
21 (1) Fenfluramine.
22 (e) Unless specifically excepted or unless listed in
23 another schedule any material, compound, mixture, or
24 preparation which contains any quantity of the following
25 substances having a stimulant effect on the central nervous
26 system, including its salts, isomers (whether optical,
27 position or geometric), and salts of such isomers whenever
28 the existence of such salts, isomers, and salts of isomers is
29 possible within the specific chemical designation:
30 (1) Cathine ((+)-norpseudoephedrine);
31 (1.1) Diethylpropion;
32 (1.2) Fencamfamin;
33 (1.3) Fenproporex;
34 (2) Mazindol;
-20- LRB9104866DJcdam04
1 (2.1) Mefenorex;
2 (3) Phentermine;
3 (4) Pemoline (including organometallic complexes
4 and chelates thereof);
5 (5) Pipradrol;
6 (6) SPA ((-)-1-dimethylamino-1, 2-diphenylethane);.
7 (7) Modafinil;
8 (8) Sibutramine.
9 (f) Other Substances. Unless specifically excepted or
10 unless listed in another schedule, any material, compound,
11 mixture, or preparation that contains any quantity of the
12 following substance, including its salts:
13 (1) Butorphanol (including its optical isomers).
14 (g) The Department may except by rule any compound,
15 mixture, or preparation containing any depressant substance
16 listed in subsection (b) from the application of all or any
17 part of this Act if the compound, mixture, or preparation
18 contains one or more active medicinal ingredients not having
19 a depressant effect on the central nervous system, and if the
20 admixtures are included therein in combinations, quantity,
21 proportion, or concentration that vitiate the potential for
22 abuse of the substances which have a depressant effect on the
23 central nervous system.
24 (h) Except as otherwise provided in Section 216, any
25 material, compound, mixture, or preparation that contains any
26 quantity of the following substance having a stimulant effect
27 on the central nervous system, including its salts,
28 enantiomers (optical isomers) and salts of enantiomers
29 (optical isomers):
30 (1) Ephedrine, its salts, optical isomers and salts
31 of optical isomers.
32 (Source: P.A. 89-202, eff. 10-1-95; 90-775, eff. 1-1-99.)
33 (720 ILCS 570/214) (from Ch. 56 1/2, par. 1214)
-21- LRB9104866DJcdam04
1 Sec. 214. Excluded Substances.
2 (a) Products containing an anabolic steroid, that are
3 expressly intended for administration through implants to
4 cattle or other nonhuman species and that have been approved
5 by the Secretary of Health and Human Services for that
6 administration, and that are excluded from all schedules
7 under Section 102(41)(B)(1) of the federal Controlled
8 Substances Act (21 U.S.C. 802(41)(B)(1)) are also excluded
9 from Sections 207 and 208 of this Act.
10 (b) The non-narcotic substances excluded from all
11 schedules of the Federal Controlled Substances Act (21 U.S.C.
12 801 et seq.) pursuant to Section 1308.22 of the Code of
13 Federal regulations (21 C.F.R. 1308.22), are excluded from
14 all schedules of this Act.
15 (Source: P.A. 80-472.)
16 (720 ILCS 570/217 new)
17 Sec. 217. Exempt anabolic steroid products. Compounds,
18 mixtures, or preparations that contain an anabolic steroid
19 that have been exempted by the Administrator of the federal
20 Drug Enforcement Administration from application of Sections
21 302 through 309 and Sections 1002 through 1004 of the federal
22 Controlled Substances Act (21 U.S.C. 822 through 829 and 952
23 through 954) and 21 CFR 1301.13, 1301.22, and 1301.71
24 through 1301.76 are also exempt from Sections 207 and 208 of
25 this Act.".